QA: ENZO Biochem INC in us_health_services/2024

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000316253_2025_ENZO_Biochem_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}
info Minor missing amount for aggregate added to remainder industry.us_generic {'aggregate': 'Expenses', 'missing_ratio': 0.4775010320627494, 'aggregate_val': 45564000, 'exp_sum': 87204000, 'exp_to_value': {'LaborExpense': 0, 'CostOfGoodsAndServicesSold': 17275000, 'GeneralAndAdministrativeExpense': 21723000, 'GoodwillImpairmentLoss': 0, 'OperatingCostsAndExpenses': 44272000, 'DepreciationDepletionAndAmortization': 0, 'SellingAndMarketingExpense': 0, 'ResearchAndDevelopmentExpense': 2642000, 'remainder_Expenses': 1292000}}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0000316253')"}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0000316253, ENZO Biochem INC

  xvar xval
0 IntangibleAssets 0
1 AssetsNonCurrent 3,366,000
2 AssetsCurrent 70,031,000
3 PropertyPlantAndEquipment 12,367,000
4 remainder_Assets 0
5 LongTermLiabilities 2,592,000
6 LiabilitiesCurrent 24,794,000
7 remainder_Liabilities 2,266,000
8 LaborExpense 0
9 CostOfGoodsAndServicesSold 17,275,000
10 GeneralAndAdministrativeExpense 21,723,000
11 GoodwillImpairmentLoss 0
12 OperatingCostsAndExpenses 44,272,000
13 DepreciationDepletionAndAmortization 0
14 SellingAndMarketingExpense 0
15 ResearchAndDevelopmentExpense 2,642,000
16 remainder_Expenses -40,348,000
17 remainder_Revenues 31,907,000
18 remainder_NetIncome -12,421,000
19 remainder_ComprehensiveNetIncome 7,000
  yvar yval
0 Assets 85,764,000
1 Liabilities 29,652,000
2 Expenses 45,564,000
3 Revenues 31,907,000
4 StockholdersEquity 56,112,000
5 NetIncome -26,078,000
6 ComprehensiveNetIncome -26,071,000
7 BaseVar 102,657,500
8 EconomicCapitalRatiobeforeLimitedLiability 0.958
9 EconomicCapitalRatio 1.68

Edgar->Model Mapping

Feature Distribution

Change over Time